Vir Biotechnology (NASDAQ:VIR – Free Report) had its price objective lowered by Needham & Company LLC from $32.00 to $22.00 in a report released on Thursday morning, Benzinga reports. Needham & Company LLC currently has a buy rating on the stock. Other equities research analysts also recently issued reports about the stock. Morgan Stanley boosted […]
Vir Biotechnology (NASDAQ:VIR – Free Report) had its price target cut by Needham & Company LLC from $32.00 to $22.00 in a research note released on Thursday morning, Benzinga reports. The firm currently has a buy rating on the stock. Several other brokerages have also commented on VIR. SVB Securities dropped their price target on […]
Vir Biotechnology (NASDAQ:VIR – Free Report) had its target price cut by Morgan Stanley from $27.00 to $15.00 in a research report report published on Friday morning, Benzinga reports. They currently have an equal weight rating on the stock. A number of other equities analysts have also issued reports on VIR. TheStreet lowered shares of […]
Vir Biotechnology (NASDAQ:VIR – Free Report) had its price target cut by Needham & Company LLC from $32.00 to $22.00 in a report published on Thursday, Benzinga reports. They currently have a buy rating on the stock. VIR has been the topic of a number of other research reports. SVB Securities reduced their price objective […]
Vir Biotechnology (NASDAQ:VIR) Given New $28 00 Price Target at The Goldman Sachs Group theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.